Loading…
New Product Planning Summit
Attending this event?

Sign up or log in to bookmark your favorites and sync them to your phone or calendar.

Tuesday, February 2
 

11:00am EST

Opening Remarks
Speakers
avatar for Tony Russell, Ph.D., M.B.A.

Tony Russell, Ph.D., M.B.A.

Executive Director, New Product Planning, Chinook Therapeutics, Inc.


Tuesday February 2, 2021 11:00am - 11:05am EST

11:05am EST

Keynote: Portfolio Management: Prioritizing Your Pipeline
  • Demonstrate how the role of portfolio management is evolving due to factors like shrinking pipelines, rising costs, reimbursement issues, and regulatory pressures 
  • Consider the right variables to make decisions that will meet corporate goals and consumer demands 
  • Determine where to prioritize budget and resources based on your scientific and commercial opportunity 

Speakers
avatar for Janet Dorling, MBA

Janet Dorling, MBA

Senior Vice President, Global Commercial Product Strategy, Gilead Sciences
Janet Dorling is a dynamic leader with more than 20 years of experience in science and business. She leads Global Commercial Product Strategy at Gilead, the team that provides the Commercial voice into the R&D process as well as global positioning, branding and access strategies for... Read More →


Tuesday February 2, 2021 11:05am - 11:30am EST

11:35am EST

Panel: Optimize Your Company’s NPP Organizational Structure and Process
  • Deliberate over the stage at which different resources, including market research, competitive intelligence, market access, pricing risk mitigation, etc., should get involved in NPP 
  • Assess what techniques or methodologies people are using to tackle their day to day  
  • Drive innovation early on when faced with limited resources 

Moderators
avatar for Anne Ollivier

Anne Ollivier

Director, New Product Planning, Global Strategic Marketing, Lundbeck

Speakers
avatar for Chris Benecchi

Chris Benecchi

Vice President, Global Head of Commercial Excellence, Alexion Pharmaceuticals
Chris has consistently delivered novel therapies to those suffering from serious conditions in both specialty care and rare disease. Through experience in US and Global commercial leadership roles at J&J, Takeda, Acorda, UCB, and now Alexion, Chris has a distinct perspective on critical... Read More →
avatar for Buket Grau

Buket Grau

Vice President, Head of Early and External Product Commercialization, Biogen
avatar for Avi Kogan, Ph.D.

Avi Kogan, Ph.D.

Senior Director, Head of New Product Commercialization, Alnylam Pharmaceuticals
Avi Kogan is the Head of New Product Commercialization at Alnylam, where he leads commercial strategy and market opportunity assessments for research, candidate, and early stage clinical programs.  Avi was previously a New Products Leader at Takeda; led Multiple Sclerosis franchise... Read More →


Tuesday February 2, 2021 11:35am - 12:20pm EST

12:20pm EST

“Meet the Speakers” Zoom Party
Missing out on the networking aspect of live events? Your question didn’t get answered during the Q&A portion of a session? Grab a snack and mingle with today’s speakers and attendees in these zoom breakout room

Tuesday February 2, 2021 12:20pm - 12:50pm EST

12:50pm EST

Assign Value Early on for New Products Through Multiple Functional Lenses
Speakers
avatar for Alexander Brown

Alexander Brown

Vice President, Global Head, New Product Planning Oncology, Sanofi Genzyme
Alex Brown has 25 years of experience developing and commercializing innovative medicines in oncology, rare and infectious diseases. In his current role Alex leads the New Products Oncology team at Sanofi-Genzyme and is responsible for the commercial readiness of the Sanofi oncology... Read More →


Tuesday February 2, 2021 12:50pm - 1:20pm EST

1:25pm EST

Panel: Virtually Justify New Product Value to Payors
  • Assess changes to market access & reimbursement landscape during pandemic 
  • Establish the most influential factors that enhance a value proposition from a payer perspective 
  • Compare perspectives from private and public payer sectors 



Moderators
avatar for Marco Rauland, Ph.D.

Marco Rauland, Ph.D.

Vice President, Global Market Access & Pricing Strategic Planning, Merck KGaA
Chirag Shah is a results-driven Medical Affairs Professional, Pharmacist, Speaker, Advisor, and Leader with vast experiences across clinical, academic, and industrial environments. His areas of expertise include medical affairs strategy and communications, publication planning and... Read More →

Speakers
avatar for Aria Cohen, MBA

Aria Cohen, MBA

Senior Director, US Market Access, Apellis Pharmaceuticals
As the Head of Payer Marketing, Aria is responsible for the strategic planning and tactical execution of US payer engagement and messaging for Apellis’ pipeline of targeted C3 therapies. Previous to his time at Apellis, Aria has spent over 20 years in the pharma, biotech and medical... Read More →
avatar for Damon Harrell

Damon Harrell

Vice President, Marketing, Psychiatry Franchise, Alkermes
With over 25 years of pharmaceutical experience, Damon Harrell has held a broad range of positions across multiple therapeutic areas, multiple geographies and product lifecycle responsibilities including new products, multiple product launches and line extensions, and patent expiration.  Damon... Read More →


Tuesday February 2, 2021 1:25pm - 2:10pm EST

2:10pm EST

"Meet the Speakers" Zoom Party
Missing out on the networking aspect of live events? Your question didn’t get answered during the Q&A portion of a session? Grab a snack and mingle with today’s speakers and attendees in these zoom breakout room

Tuesday February 2, 2021 2:10pm - 2:40pm EST

2:40pm EST

Digital Innovation for New Product Planning
Tuesday February 2, 2021 2:40pm - 3:10pm EST

3:15pm EST

Panel: Connect Supply Strategies to New Product Plans Early
  • Evaluate how and when to include supply chain in the decision-making process to drive global expansion 
  • Explore how you can speed to market with increasingly underdeveloped products 
  • Consider the effect cost of good could have on pricing implications 
  • Planning localization efforts early 

Speakers
avatar for Michael Boyson

Michael Boyson

Vice President, Product Operations for Oncology and Small Molecules, Takeda Pharmaceuticals
Mike is responsible for global operations strategy, including life-cycle planning and overall operations value management for Takeda’s oncology portfolio and select small molecule therapies.  Mike joined Takeda Oncology in 2002.  Since that time, he has held various positions... Read More →
avatar for Ram Palanki, PharmD

Ram Palanki, PharmD

Senior Vice President, Commercial Strategy & Operations, REGENXBIO Inc.
Ram has nearly 20 years of drug development and commercialization experience in biopharmaceutical industry.  He built and operationalized commercial infrastructures and launched landmark drug therapies and devices in ophthalmology.Currently, he serves as the Senior Vice President... Read More →
avatar for Csanad Varga, Ph.D.

Csanad Varga, Ph.D.

Vice President, Pharmaceutical Sciences & Manufacturing, Blueprint Medicines
Csanad “Csani” Varga, Ph.D. is the Vice President of Pharmaceutical Sciences & Manufacturing at Blueprint Medicines, responsible for the pharmaceutical development and manufacturing oversight, including drug substance, drug product, and analytical development, for Blueprint’s... Read More →


Tuesday February 2, 2021 3:15pm - 4:00pm EST
 
Wednesday, February 3
 

11:00am EST

Opening Remarks
Speakers
avatar for Tony Russell, Ph.D., M.B.A.

Tony Russell, Ph.D., M.B.A.

Executive Director, New Product Planning, Chinook Therapeutics, Inc.


Wednesday February 3, 2021 11:00am - 11:05am EST

11:05am EST

Keynote: Incorporate External Insights into Pipeline Decisions



Speakers
avatar for Aakanksha Khandelwal, Ph.D., MBA

Aakanksha Khandelwal, Ph.D., MBA

Global Head of Portfolio Strategy & Innovation, EMD Serono
Aakanksha is the Head of Global Portfolio Strategy & Innovation at EMD Serono/Merck KGaA, Darmstadt, Germany. She is a cross-functional leader with grounding in both the R&D and commercial sides of the business.​Prior, Aakanksha led the commercial launch of BAVENCIO while building... Read More →


Wednesday February 3, 2021 11:05am - 11:30am EST

11:35am EST

Panel: Comparing NPP Across Different Therapy Types: Cell therapies, Non-cell therapies, and Gene therapies
Moderators
avatar for Tony Russell, Ph.D., M.B.A.

Tony Russell, Ph.D., M.B.A.

Executive Director, New Product Planning, Chinook Therapeutics, Inc.

Speakers
avatar for Lung-I Cheng, Ph.D.

Lung-I Cheng, Ph.D.

Global Value & Access Lead, Cell Therapies, Takeda
avatar for Kelly Page

Kelly Page

Head of Global Cell Therapy Commercialization, Takeda
avatar for Jennifer Sherak

Jennifer Sherak

Global Head, Oncology New Products, Takeda
Jennifer is currently the Global Head of Oncology New Product Planning Business Development at Takeda Pharmaceuticals. In her current role, she is responsible for ensuring that the value of the oncology pipeline is maximized globally by integrating commercial insights early in development... Read More →


Wednesday February 3, 2021 11:35am - 12:20pm EST

12:20pm EST

"Meet the Speakers" Zoom Party
Missing out on the networking aspect of live events? Your question didn’t get answered during the Q&A portion of a session? Grab a snack and mingle with today’s speakers and attendees in these zoom breakout room 

Wednesday February 3, 2021 12:20pm - 12:50pm EST

12:50pm EST

Making Key Decisions in New Product Planning When “Perfect” Information is Not Available
  • Review the types of decisions typically made in New Product Planning 
  • Discuss the nature of information available to support decision-making in New Product Planning 
  • Review the impact and context of decision-making in New Product Planning 
  • Review potential approaches to assist in New Product Planning decision-making 

Speakers
avatar for Tony Russell, Ph.D., M.B.A.

Tony Russell, Ph.D., M.B.A.

Executive Director, New Product Planning, Chinook Therapeutics, Inc.


Wednesday February 3, 2021 12:50pm - 1:20pm EST

1:25pm EST

Panel: How Does Working in the Covid-19 Era Affect Forecasting and New Product Planning
  • Discuss when in the product pipeline to begin forecasting, and how covid-19 has affected that timeline  
  • Determine the best resources to use for forecasting  
  • Consider which functional areas forecasting has an influence on and how   
  • What has worked for different companies? What has been challenging?   

Moderators
avatar for Alex Drigan, MBA

Alex Drigan, MBA

Senior Director, Commercial Operations, Amneal Pharmaceuticals

Speakers
avatar for Charlie Pak, Ph.D., MBA

Charlie Pak, Ph.D., MBA

Executive Director, New Product Planning, Alkermes
Charlie Pak is currently the Executive Director of New Product Planning at Alkermes with responsibility across oncology and neuroscience.  He has extensive new product planning experience at various companies, including Syros Pharmaceuticals, ImmunoGen, Eisai, and Vertex Pharmaceuticals... Read More →


Wednesday February 3, 2021 1:25pm - 2:10pm EST

2:10pm EST

"Meet the Speakers" Zoom Party
Missing out on the networking aspect of live events? Your question didn’t get answered during the Q&A portion of a session? Grab a snack and mingle with today’s speakers and attendees in these zoom breakout room 

Wednesday February 3, 2021 2:10pm - 2:40pm EST

2:40pm EST

Evaluate How and Why to Include Patient Voice into your Product Development Plans
Speakers
avatar for Katja Wachtendonk, PharmD

Katja Wachtendonk, PharmD

Executive Director, Global Marketing (New Products), Novartis


Wednesday February 3, 2021 2:40pm - 3:10pm EST

3:15pm EST

Panel: Assess how a Target Product Profile Can Help Guide R&D, Regulatory, and Other Stakeholders
  • Outline how a TPP can set up your clinical program and commercial model for success 
  • Determine how to develop an insights program that allows you to get the information and apply it effectively 

Moderators
avatar for Lillian Cao, MBA

Lillian Cao, MBA

Director, New Product Planning, Taiho Oncology

Speakers
avatar for Sophie Desbiens, Ph.D.

Sophie Desbiens, Ph.D.

Director of New Product Commercialization, Alnylam Pharmaceuticals
Sophie Desbiens, Ph.D., is Director of New Product Commercialization at Alnylam. Prior to joining Alnylam, Sophie worked at Genentech/Roche, where she held commercial and insights roles in Global Product Strategy. She also led the Data Program at NEWDIGS, an MIT-based consortium fostering... Read More →
avatar for Elaine Hughes

Elaine Hughes

Executive Director, Commercial Development, Bristol Myers Squibb
Elaine Hughes is Executive Director, Commercial Development for Immunology, Fibrosis & Neurology at BMS, leading New Product Planning and Business Development for those therapeutic areas. In this role, she and her team manage a portfolio of nearly 30 products from Discovery to Phase... Read More →
avatar for Jehan Tamboowalla

Jehan Tamboowalla

Vice President, Head of New Products, Ophthalmology, Novartis Pharmaceuticals


Wednesday February 3, 2021 3:15pm - 4:00pm EST